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Accepted 9 March 2016Objective: Associations between age and patient-reported quality of family planning services were examined
among young women in Mexico.Methods: A repeated cross-sectional analysis of survey data collected in 2006,
2009, and 2014 was performed. Data from women aged 15–29 years who had not undergone sterilization and
were currently using a modern contraceptive method were included. The primary outcome was high-quality
care, deﬁned as positive responses to all ﬁve quality items regarding contraceptive services included in the
survey. Multivariable logistic regression and marginal probabilities were used to compare adolescents and
women aged 20–29 years. The responses of respondents using different contraceptive methods were compared.
Results: Data were included from 15 835 individuals. The multivariable analysis demonstrated lower odds of
reporting high-quality care among women aged 15–19 years (odds ratio 0.73; 95% conﬁdence interval
0.60–0.88) and 20–24 years (odds ratio 0.85; 95% conﬁdence interval 0.75–0.96) compared with women aged
25–29 years. Adolescents using hormonal and long-acting reversible contraception had signiﬁcantly lower
odds of reporting high-quality care compared with women aged 25–29. Conclusions: Adolescents in Mexico
reported a lower quality of family planning services compared with young adult women. Continued research
and policies are needed to improve the quality of contraceptive services.








Unintended pregnancy is a public health problem globally, and the
morbidity and mortality risks of unintended pregnancy are magniﬁed
in adolescents [1,2]. Effective contraception is a key strategy in
preventing unintended pregnancy and improving health outcomes in
adolescents [3]. Evidence suggests that the quality of contraceptive
services is linked to the uptake and continuation of contraceptive
methods [4,5].WHOhas identiﬁed the quality of services as a core health
and human rights principle in the provision of contraceptive services [6].
Quality of health care has been deﬁned as the extent to which
healthcare services improve health outcomes consistent with current
professional knowledge [7]. To be considered high quality, healthcare
should be safe, effective, patient centered, timely, efﬁcient, ande XXI FIGO World Congress of
r, BC, Canada.
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y and Obstetrics. Published by Elseviaccessible [7]. Frameworks for measuring the quality of family-
planning services [6,8,9] draw on the broader healthcare literature,
and emphasize both the technical and interpersonal domains of quality
[10,11]; technical quality is concernedwith the application of evidence-
based medicine and interpersonal quality focuses on provider–patient
interactions [10].
Globally, signiﬁcant disparities in contraceptive use persist despite
overall declines in fertility and improvements in female education
[12]. In Mexico, access to contraception is embedded in national policy
[13]. However, despite large declines in fertility generally, adolescent
fertility in Mexico has remained a persistent health problem [14], and
contraceptive use remains low among adolescents, especially among
adolescents in rural areas [15,16].
Quality of care is increasingly recognized as an important element in
improving health outcomes and fulﬁlling human-rights obligations [6];
however, discrepancies in service quality for adolescents are well
documented [17]. To meet the reproductive-health needs of a growing
global population of adolescents and young people, it is essential that
these patients' perceptions of care quality are understood.
The aim of the present study was to test associations between age
and patient-reported quality of family planning services among a
population of patients in Mexico using modern contraceptives whoer Ireland Ltd. All rights reserved.
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would report lower care quality in comparison with women aged
20–29 years, and that the reported quality would vary based on the
method of contraception used.
2. Materials and methods
A repeated cross-sectional studywas performed between February 1
and August 31, 2015 using survey data collected in 2006, 2009, and
2014. The data were generated by the “Encuesta Nacional de la
Dinámica Demográﬁca”, a nationally representative survey employing
two-stage stratiﬁed probability sampling from Mexico's 31 states and
Mexico City [18–20]. Each survey had a high response rate (85%, 89%,
and 91%, respectively) and included household and reproductive-
history modules [18–20]. The present study included women aged
15–29 years who had not undergone sterilization and who were
currently using a modern contraceptivemethod (excludingwithdrawal
and rhythmmethods) that had been obtained from a healthcare facility.
Outcome data were extracted from ﬁve survey questions regarding the
quality of individual's family-planning visits; data on survey respondent
characteristics were also retrieved. For the present study, the responses
to these questionswere grouped as technical or interpersonal measures
of quality (Supplementary Material S1 and Table 1). The present study
was approved by the Research Ethics Committee at the National Insti-
tute of Public Health, Cuernavaca, Mexico. Informed consent was
waived for the present secondary analysis because it used de-
identiﬁed, publically available data.
The primary outcome was if individuals reported receiving high-
quality care, deﬁned by individuals giving a “yes” response to all ﬁve
quality items included in the present study. The secondary outcomes
were positive responses to the three questions classiﬁed as technical-
quality items and to the two questions classiﬁed as interpersonal-
quality items. The key independent variable was age, grouped as
15–19 years, 20–24 years, and 25–29 years.
Current contraceptive methods were deﬁned as long-acting
reversible contraception (LARC), hormonal contraception (pills, patch,
progestin injectable), and condoms. If individuals reported using two
methods, they were classiﬁed according to the most effective method
used (e.g. a person who reported using oral contraceptives and
condoms would be classiﬁed as using hormonal contraception).
Several individual and household-level characteristics that could in-
ﬂuence perceptions of quality and contraceptive choices were included
as variables in the analysis. An “education gap” was calculated for each
survey respondent; this was deﬁned as the number of years, or fraction
thereof, of schooling completed by an individual compared with the
length of schooling that would be expected given the individual's age.
This variable allows comparison between adolescents, who could still
be in school, with adults who have completed their education.
Women were classiﬁed as having ever been married (including di-
vorced and widowed) or cohabited, or not. Other variables included
whether respondents had reported any type of employment outside
the home in the week prior to completing the survey, the number of
live deliveries they had experienced, andwhether they reported having
health insurance. Health insurancewas classiﬁed as being employment-
based, public insurance for those in the informal sector (Seguro
Popular), or no insurance. It was hypothesized that having health
insurance would not be associated with any particular method of con-
traception because contraception is theoretically available to all
women in Mexico regardless of insurance status; however, having
health insurance could be related to other health-seeking behaviors.
Finally, where individuals reported obtaining contraception was classi-
ﬁed as being either a public, employment-based, or private facility.
Respondent households were classiﬁed according to whether the
head of the household spoke an indigenous language, the preferred
classiﬁcation of indigenous ethnicity used by the Mexican government.
The gender of the household head and the presence of large households(N6 people) were included as markers of poverty. Additionally, a
household-levelwealth indexwas constructed using data for household
characteristics and property using factor analysis; this index was col-
lapsed into quintiles. Whether households were in a rural location
(b2500 inhabitants) or not was recorded, and indicator variables for
the 31Mexican states andMexico Citywere included. Finally, an indica-
tor for survey year (2006, 2009, and 2014)was included in the analyses.
Descriptive statistics and bivariate tests (χ2 test or Student t test)
were used to examine differences in outcomes and covariates between
respondent age groups, and to describe trends in outcomes across sur-
vey years and age groups. Multivariable logistic regression models in-
cluding all the study variables were used to examine the relationship
between age and if respondents received high-quality care. Following
this, a model was developed that was stratiﬁed by the contraceptive
method used (separate models for LARC, hormonal contraception, and
condoms); this model was applied to investigate associations between
respondent variables and if respondents reported receiving high-
quality care. Several sensitivity analyses were performed, examining
interactions between potential effect modiﬁers and respondent age.
The household-level wealth index variable contained considerable
missing data (8.4% of values missing) (Supplementary Material S2);
consequently, models were constructed without this variable to test
the robustness of the models to the missing data.
Survey weights were used to account for the complex survey design
and to produce population estimates. Marginal effects were calculated
to simplify data interpretation (multivariable estimates of changes in
probability that accounted for covariates). In the bivariate analysis,
P b 0.05 was considered signiﬁcant. In the multivariable analyses, odds
ratios (ORs) not including 1.0 in the 95% conﬁdence interval (CI), and
predicted or marginal probabilities without overlapping CIs were con-
sidered signiﬁcant. Stata 13.0 (StataCorp LP, College Station, TX, USA)
was used for all analyses.
3. Results
The present study sample included 15 835women aged 15–29 years
who reported using amodern contraceptive that had been obtained at a
healthcare facility. Among the complete estimated study population
(N = 6 082 045), 13% were aged 15–19 years old, 42% were aged
20–24 years, and 45% were aged 25-29 years (Table 1). In comparison
withwomen aged 20–24 and 25–29, fewer adolescents reported having
ever been married or cohabited, and adolescents reported fewer
previous live deliveries. Additionally, a larger proportion of adolescents
reported having Seguro Popular insurance (Table 1).
When examining respondents' contraceptive use, in comparison
with women aged 20–24 and 25–29, signiﬁcantly more adolescents re-
ported exclusive condomuse. A lower proportion of adolescents report-
ed LARC use in comparison with older individuals; however, this
difference was not statistically signiﬁcant. The overall difference in
contraceptive methods used reported between the age groups was
signiﬁcant (P = 0.03) (Table 1). The proportion of adolescents who
reported obtaining contraception at public healthcare facilities was
signiﬁcantly higher than in each of the 20–24-years and 25–29-years
age groups (Table 1).
The primary outcome, positive responses to all ﬁve quality items,
was recorded for 61.0% of adolescents, 65.0% of women aged
20–24 years, and 67.0% of women aged 25–29 years; signiﬁcant differ-
ences with the 25–29 year age group were observed for both adoles-
cents (P b 0.001) and women aged 20–24 years (P = 0.03) (Fig. 1).
Across the complete study population, the individual quality item re-
ported by the fewest respondents was, “I was given enough time for
all the information needed” (Table 1). The quality item, “possible side
effectswere explained”, was reported by signiﬁcantly fewer adolescents
comparedwithwomen aged 25–29 years. In all three age groups includ-
ed in the study, the proportion of positive answers to all ﬁve quality
items, the three technical items, and the two interpersonal items
Table 1
Sociodemographic and contraception characteristics of female survey respondents aged 15–29 years using modern contraception obtained from a healthcare facility (n = 15 835;
N = 6 082 045). a
Variable Sample survey respondents P value
Complete sample
(n = 15 835;
N = 6 082 045)
Individuals aged
15–19 y (n = 2307;
N = 814 994)
Individuals aged
20–24 y (n = 6612;
N = 2 554 458)
Individuals aged
25–29 y (n = 6916;
N = 2 736 920)
Educational gap, y b,c 0.91 (0.86–0.95) 0.93 (0.82–1.03) 0.76 (0.70–0.83) 1.04 (0.96–1.11) 0.002
Respondents have ever been married or co-habited 90.3 (89.6–91.0) 86.0 (83.8–88.0) 89.5 (88.3–90.6) 92.4 (91.4–93.4) b0.001
Currently working 31.3 (30.2–32.4) 17.1 (15.1–19.4) 30.2 (28.5–31.9) 36.7 (35.0–38.4) b0.001
Previous number of live deliveries c 1.65 (1.63–1.67) 1.18 (1.14–1.22) 1.49 (1.47–1.52) 1.94 (1.90–1.97) b0.001
Reported ever being pregnant 93.6 (93.0–94.1) 88.7 (86.6–90.4) 93.2 (92.2–94.1) 95.4 (94.7–96.1) b0.001
Health insurance 0.001
None 30.3 (29.0–31.6) 33.1 (30.1–36.1) 31.1 (29.2–33.1) 28.7 (26.9–30.4)
Employment based 34.9 (33.7–36.1) 20.1 (17.8–22.5) 33.8 (32.0–35.6) 40.4 (38.6–42.2)
Seguro Popular 34.8 (33.6–36.1) 46.9 (43.8–49.9) 35.1 (33.4–36.9) 31.0 (29.4–32.6)
Household characteristics
Head of household speaks an indigenous language 7.1 (6.4–7.8) 7.7 (6.3–9.4) 7.3 (6.4–8.3) 6.6 (5.8–7.6) 0.119
Male head of household 81.3 (80.3–82.2) 76.9 (74.2–79.4) 81.1 (79.6–82.5) 82.8 (81.4–84.1) b0.001
Household size ≥6 people 30.9 (29.7–32.1) 41.4 (38.4–44.4) 33.2 (31.4–35.0) 25.6 (24.0–27.3) b0.001
Household wealth quintile b0.001
1 (Poorest) 24.3 (23.3–25.4) 27.7 (24.9–30.6) 24.5 (23.0–26.1) 23.1 (21.7–24.7)
2 24.9 (23.8–26.0) 26.1 (23.4–29.0) 25.2 (23.6–27.0) 24.2 (22.7–25.8)
3 21.7 (20.7–22.8) 21.2 (18.8–23.8) 22.0 (20.4–23.7) 21.6 (20.2–23.2)
4 17.8 (16.8–18.9) 16.2 (13.9–18.8) 16.9 (15.4–18.5) 19.1 (17.7–20.7)
5 (Wealthiest) 11.3 (10.5–12.1) 8.8 (7.2–10.8) 11.4 (10.2–12.6) 11.9 (10.9–13.1)
Rural locality (population ≤ 2500) 24.8 (23.7–26.0) 28.9 (26.3–31.7) 25.2 (23.6–26.9) 23.2 (21.8–24.6) b0.001
Contraceptive 0.033
Hormonal 22.3 (21.3–23.3) 21.1 (18.8–23.5) 22.3 (20.8–23.8) 22.7 (21.3–24.2)
Long-acting reversible contraction 67.5 (66.3–68.5) 65.2 (62.3–68.0) 67.7 (66.0–69.4) 67.9 (66.3–69.5)
Condoms 10.2 (9.6–11.0) 13.8 (11.8–16.0) 10.0 (9.1–11.1) 9.4 (8.4–10.5)
Source of contraception b0.001
Employment-based facility 35.7 (34.6–36.9) 23.2 (20.8–25.7) 35.2 (33.5–37.0) 40.0 (38.2–41.7)
Public facility 53.7 (52.5–54.9) 68.6 (65.7–71.3) 55.0 (53.2–56.9) 47.9 (46.1–49.7)
Private facility 10.6 (9.8–11.4) 8.2 (6.5–10.4) 9.7 (8.6–11.0) 12.1 (10.9–13.4)
Individual received their requested method of contraception 93.8 (93.2–94.3) 91.3 (89.5–92.9) 93.3 (92.3–94.1) 95.1 (94.4–95.7) b0.001
Technical quality items
Individual received information on other contraceptives 81.0 (80.0–82.0) 79.2 (76.5–81.6) 81.2 (79.7–82.7) 81.3 (79.9–82.7) 0.230
Possible adverse effects were explained 78.2 (77.2–79.3) 74.2 (71.5–76.8) 78.1 (76.4–79.6) 79.6 (78.2–81.0) 0.001
Individual was told to return if adverse effects occurred 85.8 (85.0–86.6) 82.3 (79.8–84.6) 85.9 (84.6–87.1) 86.8 (85.6–88.0) 0.002
Interpersonal quality items
Individual reported being given sufﬁcient time for all the
information needed
76.3 (75.2–77.2) 74.0 (71.2–76.6) 75.1 (73.4–76.8) 78.0 (76.5–79.4) 0.003
All an individual's doubts about the contraceptive were
addressed
78.8 (77.8–79.7) 76.3 (73.6–78.8) 77.7 (76.2–79.2) 80.5 (79.1–81.8) 0.001
a Values are given as weighted percentage of respondents (95% conﬁdence interval) unless indicated otherwise.
b Deﬁned as the number of years of schooling completed by an individual expressed as a fraction of the number of years of completed schooling that would be expected given
the individual's age.
c Values given as mean (95% conﬁdence interval).
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groups, increases in the proportion of positive answers to all ﬁve quality
items was driven by increases in positive responses to the three techni-
cal items; the proportion of adolescents responding positively to all
three technical items increased from 59.5% to 69.2% between 2006
and 2014 (P= 0.02).
In the multivariable analyses, individuals aged 15–19 years (OR
0.73; 95%CI 0.60–0.88) and 20–24 years (OR 0.85; 95%CI 0.75–0.96),
were less likely to answer positively to all ﬁve quality items in compar-
ison with women who were aged 25–29 years (Table 2). This
corresponded to an 8% reduction in the multivariable probability of
positive responses to all ﬁve quality items among adolescents in com-
parison with women aged 25–29 years (assuming the means of all
other covariates were maintained). Covariates that were signiﬁcantly
associated with positive responses to all quality items were individuals
receiving the method of contraception they requested compared with
those who did not, and being in the highest household wealth quintile
compared with the poorest. Women with a larger educational gaps
or living in indigenous households demonstrated lower odds ofresponding positively to all quality items. The ORs of responding
positively were very similar when considering the technical and inter-
personal items separately (Table 2).
Similar results were demonstrated in the sensitivity analyses when
the household-level wealth variable was not included in the model to
reduce the number of observations excluded from the multivariable
models (data not shown). No evidence of effect modiﬁcation (non-
signiﬁcant interactions, data not shown) was found and so effect
modiﬁers were not considered further.
When the model was stratiﬁed by the contraceptive method used
(Table 3), the associations observed remained consistent with those
produced by the pooled data model. Adolescents using hormonal con-
traception were signiﬁcantly less likely to respond positively to all ﬁve
quality items compared with women aged 25–29 years using
hormonal contraception. This corresponded to a 9% reduction in the
multivariable probability of positive answers across all ﬁve quality
items for adolescents using hormonal contraception in comparison
with women aged 25–29 years using hormonal contraception
(assuming the means of all other covariates were maintained). Both
Fig. 1. Positive responses to contraceptive healthcare quality items. Comparisons made
using χ2 test (Ref. 25-29-y age group): a P = 0.001; b Comparison with 25–29-y group
(χ2) P = 0.001; c Comparison with 25–29-y group (χ2) P b 0.001; d Comparison with
25–29-y group (χ2) P = 0.097; e Comparison with 25–29-y group (χ2) P = 0.020;
f Comparison with 25–29-y group (χ2) P = 0.033.
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onstrated lower odds of receiving high-quality care in comparison
withwomen aged 25–29 yearswhowere using LARC. Across all individ-
uals who were using LARC included in the present study, larger odds of
responding positively to all ﬁve quality itemswere recorded in the 2014
survey data compared with the 2006 survey data (Table 3).
4. Discussion
The present study identiﬁed reduced patient-reported quality of
care for family planning among adolescents in comparison with olderFig. 2.Positive responses to contraceptive healthcare quality items at eachof the three survey ye
0.003; e P= 407; f P= 0.023; g P= 0.567; h P= 0.071; i P= 0.780; j P= 0.032; k P= 0.928;young women. Only 61.0% of adolescents responded positively to all
ﬁve quality items, compared with 65.0% of women aged 20–24 years
and 67.0% of women aged 25–29 years. Additionally, in comparison
with women aged 25–29 years, both adolescents (15–19 years) and
women aged 20–24 years whowere currently usingmodern contracep-
tion that had been obtained at a healthcare facilitywere less likely to re-
port receiving high-quality care. The results of the study suggest that
self-reported care quality has increased for all three age groups
between 2006 and 2014. Additionally, the study demonstrated that ad-
olescents who were using hormonal contraception were signiﬁcantly
less likely to respond positively to all ﬁve quality items compared with
women aged 25–29 years who were using hormonal contraception.
Speciﬁcally, more adolescents reported not having their concerns
about side effects addressed compared with women aged 25–29 years.
These ﬁndings suggest that gaps exist in the quality of care received
by adolescents and older women.
Very limited data exist regarding associations between age and
differences in the quality of reproductive healthcare services [21].
Quality of healthcare is a concept that has multiple dimensions
[6,7,11]. The Bruce-Jain framework [8] has been used to measure care
quality in family planning programs for a long time; however, new
guidance from WHO highlights the need to include further elements
including the perspectives of individual patients [6]. The key weakness
of patient-reported quality measures is that patients' memories and as-
sessments of quality may not always be accurate, especially regarding
technical quality. However, individuals are best placed to judge their
own experiences of care. Comprehensive quality assessments are need-
ed that rely on data from providers and patients, including observations
and assessments of structures, processes, and health outcomes [22].
Valid and robust measures of patient-reported quality in reproductive
healthcare are needed that both reﬂect local context and permit
comparisons across studies and populations.
Low- and middle-income countries have placed signiﬁcant em-
phasis on readiness to provide reproductive healthcare services; how-
ever, the implementation of guidelines and other evidence-based carears. Comparisonsmade using χ2 test (Ref. 2006): a P=0.114; b P b 0.001; c P=0.518; d P=
l P= 0.815; m P= 0.140; n P= 0.001; o P= 0.588; p P= 0.013; q P= 0.935; r P= 0.170.
Table 2
Multivariable analysis of associations between the age of survey respondents and the reported quality of contraceptive services (n = 13 297; N = 5 056 173). a,b
Variable Positive answers to all ﬁve
quality measures
Positive answers to all three
technical quality measures
Positive answers to both
interpersonal quality measures
Age, y
15–19 0.73 (0.60–0.88) 0.77 (0.63–0.94) 0.78 (0.64–0.96)
20–24 0.85 (0.75–0.96) 0.88 (0.77–0.99) 0.82 (0.72–0.94)
25–29 Ref. Ref. Ref.
Education gap, y 0.91 (0.88–0.94) 0.92 (0.88–0.95) 0.93 (0.90–0.96)
Respondents have ever been married or co-habited
Yes 0.95 (0.75–1.20) 0.98 (0.77–1.24) 0.97 (0.76–1.25)
No Ref. Ref. Ref.
Currently working
Yes 1.03 (0.90–1.16) 1.05 (0.92–1.20) 1.02 (0.88–1.17)
No Ref. Ref. Ref.
No. of previous live deliveries 0.98 (0.91–1.05) 0.99 (0.91–1.06) 0.98 (0.91–1.06)
Individual received their requested method of contraception
Yes 3.00 (2.41–3.73) 3.21 (2.58–3.98) 2.79 (2.25–3.45)
No Ref. Ref. Ref.
Health insurance
Employment based 0.90 (0.77–1.04) 0.92 (0.79–1.07) 0.91 (0.77–1.07)
None 1.10 (0.94–1.29) 1.17 (0.99–1.38) 1.03 (0.86–1.22)
Seguro Popular Ref. Ref. Ref.
Source of contraception
Employment-based facility 1.05 (0.90–1.22) 1.08 (0.92–1.26) 1.06 (0.90–1.23)
Private facility 1.48 (1.15–1.90) 1.52 (1.15–1.99) 1.88 (1.38–2.55)
Public facility Ref. Ref. Ref.
Head of household speaks an indigenous language
Yes 0.78 (0.61–0.99) 0.76 (0.59–0.97) 0.85 (0.681–1.06)
No Ref. Ref. Ref.
Male head of household
Yes 0.98 (0.84–1.14) 1.00 (0.84–1.17) 1.04 (0.87–1.23)
No Ref. Ref. Ref.
Household size ≥6 people
Yes 1.00 (0.88–1.13) 1.01 (0.88–1.14) 0.97 (0.85–1.10)
No Ref. Ref. Ref.
Household wealth quintile
1 (Poorest) Ref. Ref. Ref.
2 1.11 (0.95–1.30) 1.15 (0.98–1.35) 1.18 (0.99–1.39)
3 1.26 (1.05–1.51) 1.35 (1.11–1.62) 1.23 (1.01–1.49)
4 1.50 (1.22–1.84) 1.51 (1.21–1.87) 1.51 (1.19–1.90)
5 (Wealthiest) 1.48 (1.16–1.87) 1.44 (1.12–1.84) 1.43 (1.10–1.85)
Rural locality (population ≤ 2500)
Yes 1.21 (1.06–1.37) 1.21 (1.05–1.38) 1.17 (1.017–1.34)
No Ref. Ref. Ref.
Survey year
2006 Ref. Ref. Ref.
2009 1.05 (0.89–1.24) 1.12 (0.94–1.32) 1.04 (0.87–1.23)
2014 1.24 (1.04–1.47) 1.37 (1.14–1.63) 1.20 (1.00–1.44)
a Values are given as odds ratios (95% conﬁdence interval).
b The models used were adjusted according to the state that was the source of the data; consequently, 32 dummy variables were included.
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hind [23]. In addition, changes in policy do not always translate into
improvements in care quality [24]. By way of example, access to con-
traception, and the topic of adolescent pregnancy in particular, have
been high on the policy agenda in Mexico [13,25]; however, although
per-capita spending on family planning has increased dramatically
(from 59 Mexican Pesos in 2009 to 150 Pesos in 2012 [Personal com-
munication: Ileana Heredia-Pi, Instituto Nacional de Salud Publica,
November, 2015]), it remains below the guideline levels (US$ 16 in
2003 [26]). The present study provides evidence that quality of care
could be improving over time, and it is essential that outcomes and
patient-reported quality continue to be monitored. This is especially
important in the public sector, as investment in family planning in
Mexico increases.
The present study had limitations that are common to all observa-
tional studies. It is unknown how much time passed between respon-
dents receiving contraceptives and responding to surveys; this could
lead to recall bias. This is one of the reasons women older than 29 and
individuals who had undergone sterilization were not included; it
was considered likely that the individuals could have receivedcontraceptives a considerable time before responding to surveys. Fur-
ther, the present study only included individuals who were currently
using contraception. Data were not included regarding individuals
who had sought care but were not using contraception; these individ-
uals could have reported lower quality than respondents who were
using contraception. Consequently, the present study cannot provide
information regarding the relationship between care quality and the
uptake or continuation of contraception, which has been the focus of
previous research [4,5,27]. However, the present study's focus on pa-
tient experiences of quality is consistent with current thinking about
care quality in a human rights framework [6]. Finally, data were not col-
lected for adolescents younger than 15 years of age, an important and
vulnerable group.
Lessons learned fromexperience inMexico can be used to guide other
low- and middle-income countries, which continue to demonstrate high
adolescent fertility despite policy and programmatic efforts to counter
this. In the present study, adolescents were more likely to report low-
quality care than women aged 20–24 years and 25–29 years. Continued
effort is needed tomeasure and improve the quality of contraceptive ser-
vices for all women; the results of the present study suggest there is
Table 3
Multivariable analysis of associations between positive response to all ﬁve quality items and different contraceptives used (n = 13 247; N = 5 016 835). a,b
Variable Hormonal contraception Long-acting reversible contraception Condoms
Age, y
15–19 0.60 (0.41–0.88) 0.72 (0.57–0.91) 1.08 (0.59–1.95)
20–24 0.98 (0.74–1.27) 0.79 (0.67–0.91) 1.02 (0.70–1.47)
25–29 Ref. Ref. Ref.
Education gap, y 0.89 (0.84–0.95) 0.92 (0.88–0.95) 0.88 (0.79–0.96)
Respondents have ever been married or co-habited
Yes 1.04 (0.56–1.92) 0.92 (0.71–1.19) 1.96 (0.70–5.45)
No Ref. Ref. Ref.
Currently working
Yes 1.24 (0.91–1.66) 0.96 (0.81–1.11) 0.96 (0.63–1.46)
No Ref. Ref. Ref.
No. of previous live deliveries 0.88 (0.75–1.01) 1.01 (0.91–1.10) 1.04 (0.83–1.28)
Individual received their requested method of contraception
Yes 2.65 (1.67–4.19) 3.69 (2.82–4.81) 1.20 (0.62–2.30)
No Ref. Ref. Ref.
Health insurance
Employment based 0.98 (0.70–1.35) 0.86 (0.70–1.03) 0.95 (0.59–1.53)
None 1.14 (0.78–1.67) 1.20 (0.98–1.45) 0.84 (0.52–1.35)
Seguro Popular Ref. Ref. Ref.
Source of contraception
Employment-based facility 0.81 (0.55–1.17) 1.11 (0.93–1.32) 1.20 (0.74–1.92)
Private facility 1.01 (0.60–1.67) 1.65 (1.22–2.21) 0.50 (0.13–1.83)
Public facility Ref. Ref. Ref.
Head of household speaks an indigenous language
Yes 0.58 (0.35–0.94) 0.81 (0.62–1.05) 1.03 (0.54–1.96)
No Ref. Ref. Ref.
Male head of household
Yes 1.03 (0.72–1.44) 0.97 (0.81–1.16) 0.79 (0.48–1.27)
No Ref. Ref. Ref.
Household size ≥6 people
Yes 0.85 (0.65–1.12) 1.06 (0.91–1.22) 1.21 (0.80–1.81)
No Ref. Ref. Ref.
Household wealth quintile
1 (Poorest) Ref. Ref. Ref.
2 0.95 (0.68–1.32) 1.15 (0.94–1.39) 1.27 (0.81–1.96)
3 1.12 (0.74–1.69) 1.34 (1.08–1.65) 1.26 (0.74–2.11)
4 1.63 (0.98–2.70) 1.49 (1.16–1.90) 1.86 (0.97–3.55)
5 (Wealthiest) 2.72 (1.45–5.11) 1.33 (1.01–1.73) 3.18 (1.41–7.17)
Rural locality (population ≤ 2500)
Yes 0.95 (0.74–1.20) 1.32 (1.12–1.55) 1.44 (0.99–2.08)
No Ref. Ref. Ref.
Survey year
2006 Ref. Ref. Ref.
2009 0.91 (0.65–1.25) 1.13 (0.91–1.39) 0.91 (0.57–1.45)
2014 1.07 (0.75–1.52) 1.35 (1.09–1.67) 1.02 (0.62–1.65)
a Values are given as odds ratios (95% conﬁdence interval).
b The models used were adjusted according to the state that was the source of the data; consequently, 32 dummy variables were included.
27B.G. Darney et al. / International Journal of Gynecology and Obstetrics 134 (2016) 22–28additional work to be done to meet the needs of adolescents, both to en-
sure human rights and to prevent unintended pregnancies.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijgo.2015.12.003.
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